Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Resimmune> ?p ?o }
Showing triples 1 to 55 of
55
with 100 triples per page.
- Resimmune abstract "Resimmune or A-dmDT390-bisFv(UCHT1) is an experimental drug — an anti-T cell immunotoxin — that is being investigated for treatment of T cell blood cancers such as cutaneous T cell lymphoma (CTCL). It was developed by Doctors Neville, Woo, and Liu while at the National Institutes of Health (NIH) and is under exclusive license to Angimmune, LLC. The therapy has potential applications for lymphomas and T cell driven autoimmune diseases, including multiple sclerosis, and graft-versus-host disease following stem cell or bone marrow transplant.".
- Resimmune atcPrefix "none".
- Resimmune iupacName "A-dmDT390-bisFv(UCHT1)".
- Resimmune wikiPageExternalLink cutaneous-lymphoma-cancer-trial.
- Resimmune wikiPageExternalLink cutaneous-t-cell-lymphoma-clinical-trials.html.
- Resimmune wikiPageID "37461277".
- Resimmune wikiPageLength "7686".
- Resimmune wikiPageOutDegree "12".
- Resimmune wikiPageRevisionID "691443416".
- Resimmune wikiPageWikiLink Autoimmune_disease.
- Resimmune wikiPageWikiLink Category:Antineoplastic_drugs.
- Resimmune wikiPageWikiLink Category:Articles_created_via_the_Article_Wizard.
- Resimmune wikiPageWikiLink Category:Experimental_cancer_treatments.
- Resimmune wikiPageWikiLink Cutaneous_T_cell_lymphoma.
- Resimmune wikiPageWikiLink Diphtheria_toxin.
- Resimmune wikiPageWikiLink Graft-versus-host_disease.
- Resimmune wikiPageWikiLink Immunotherapy.
- Resimmune wikiPageWikiLink Immunotoxin.
- Resimmune wikiPageWikiLink Multiple_sclerosis.
- Resimmune wikiPageWikiLink National_Institutes_of_Health.
- Resimmune wikiPageWikiLink T_cell.
- Resimmune wikiPageWikiLinkText "Resimmune".
- Resimmune atcPrefix "none".
- Resimmune chemspiderid "none".
- Resimmune eliminationHalfLife "-3960.0".
- Resimmune iupacName "A-dmDT390-bisFv".
- Resimmune legalStatus "Experimental".
- Resimmune pregnancyUs "C".
- Resimmune routesOfAdministration "Intravenous".
- Resimmune tradename "Resimmune".
- Resimmune wikiPageUsesTemplate Template:Chemspidercite.
- Resimmune wikiPageUsesTemplate Template:Drugbankcite.
- Resimmune wikiPageUsesTemplate Template:Drugbox.
- Resimmune wikiPageUsesTemplate Template:Ebicite.
- Resimmune wikiPageUsesTemplate Template:Fdacite.
- Resimmune wikiPageUsesTemplate Template:Reflist.
- Resimmune subject Category:Antineoplastic_drugs.
- Resimmune subject Category:Articles_created_via_the_Article_Wizard.
- Resimmune subject Category:Experimental_cancer_treatments.
- Resimmune hypernym —.
- Resimmune type ChemicalSubstance.
- Resimmune type Drug.
- Resimmune type Work.
- Resimmune type Chemical.
- Resimmune type Drug.
- Resimmune type ChemicalObject.
- Resimmune type Thing.
- Resimmune type Q8386.
- Resimmune comment "Resimmune or A-dmDT390-bisFv(UCHT1) is an experimental drug — an anti-T cell immunotoxin — that is being investigated for treatment of T cell blood cancers such as cutaneous T cell lymphoma (CTCL). It was developed by Doctors Neville, Woo, and Liu while at the National Institutes of Health (NIH) and is under exclusive license to Angimmune, LLC.".
- Resimmune label "Resimmune".
- Resimmune sameAs Q7315559.
- Resimmune sameAs m.0nhj8wd.
- Resimmune sameAs Q7315559.
- Resimmune wasDerivedFrom Resimmune?oldid=691443416.
- Resimmune isPrimaryTopicOf Resimmune.